With a ‘Liquid Assembly Line,’ mRNA-Delivering-Nanoparticles Produced a Hundred Times Faster than Standard Microfluidic Technologies

The COVID vaccines currently being deployed were developed with unprecedented speed, but the mRNA technology at work in some of them is an equally impressive success story. Because any desired mRNA sequence can be synthesized in massive quantities, one of the biggest hurdles in a variety of mRNA therapies is the ability to package those sequences into the lipid nanoparticles that deliver them into cells.